Registry of the National Network Genomic Medicine Lung Cancer (nNGM), Linking Data on Molecular Diagnostics, Clinical Characteristics, Treatment Patterns and Outcomes of Subjects With Non-Small Cell Lung Cancer in Germany
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
Registry of the national Network Genomic Medicine Lung Cancer (nNGM), linking data on molecular diagnostics, clinical characteristics, treatment patterns and outcomes of subjects with non-small cell lung cancer (NSCLC) from 23 specialized cancer centres and more than 400 general hospitals and oncological practices in Germany
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years
• Histologically confirmed, locally advanced or metastatic NSCLC (Union for International Cancer Control \[UICC\] stage IIIb/IV; non-resectable NSCLC)
• From 07/2023: histologically confirmed NSCLC stage Ib, II, III (UICC)
Locations
Other Locations
Germany
University Hospital Cologne
RECRUITING
Cologne
Contact Information
Primary
Anna Rasokat
anna.rasokat@uk-koeln.de
004922147896992
Backup
nNGM Geschäftsstelle
NNGM-Geschaeftsstelle@uk-koeln.de
004922147896991
Time Frame
Start Date: 2018-04-01
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 30000
Related Therapeutic Areas
Sponsors
Collaborators: University Hospital Ulm, University Hospital Halle (Saale), Charite University, Berlin, Germany, University Hospital rechts der Isar Munich (TUM), Johannes Gutenberg University Mainz, University Hospital of Cologne, Helios Klinikum Emil von Behring, University Hospital Schleswig-Holstein, University Hospital, Essen, University Hospital, Bonn, University Hospital Munich (LMU), Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF), University Hospital Freiburg, Goethe University, Wuerzburg University Hospital, University Hospital Tuebingen, University Hospital Regensburg, University Hospital Carl Gustav Carus, University Hospital Erlangen, Pius-Hospital Oldenburg, Universitätsklinikum Hamburg-Eppendorf, Klinikum Hanover-Siloah Hospital, Heinrich-Heine University, Duesseldorf, Vivantes Hospital Berlin Neukölln, University Hospital Giessen and Marburg, University Hospital Heidelberg
Leads: Prof. Dr. Juergen Wolf